RedHawk Holdings Corp. (SNDD)

Market Cap	1.32K
Revenue (ttm)	1.61M
Net Income (ttm)	-1.76M
Shares Out	1.32B
EPS (ttm)	-0.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SNDD

RedHawk Holdings Corp., through its subsidiaries, engages in sale and distribution of medical devices, and sale of branded generic pharmaceutical drugs primarily in the United States and the United Kingdom. It operates in three segments: Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. The company manufactures and sells Sharps and Needle Destruction Devices; carotid artery digital non-contact thermometers; and Centri Controlled Entry System, a full body X-ray scanner. It also distributes WoundClot, a bleeding control m...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Mr. Philip C. Spizale
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNDD

Financial Performance

In 2020, SNDD's revenue was $1.13 million, an increase of 779.18% compared to the previous year's $129,006. Losses were -$1.81 million, 49.2% more than in 2019.